Antigen-specific immunotherapy has long been hailed as the ideal disease-modifying approach for type 1 diabetes, both for disease prevention and reversal. A small phase 1 trial now demonstrates safety of a peptide-based treatment in recently diagnosed adults.

中文翻译：

---

1型糖尿病的抗原特异性肽免疫疗法：安全性证明，希望有效。

长期以来，抗原特异性免疫疗法一直被认为是预防和逆转1型糖尿病的理想疾病缓解方法。一项小型的1期试验现在证明了在最近被诊断的成年人中基于肽的治疗的安全性。